Consortium to Develop Fully Implantable Brain-Computer Interface to Enable Communication for People with Paralysis

A research consortium led by the UMC Utrecht Brain Center (the Netherlands) in collaboration with Graz University of Technology (Austria), the Wyss Center for Bio and Neuroengineering (Switzerland) and CorTec (Germany) is to receive a grant through the European Innovation Council (EIC) Pathfinder Challenge mechanism.

The researchers aim to develop a unique fully implantable Brain-Computer Interface (BCI) system for people with locked-in syndrome (LIS) - a condition in which paralysis severely limits communication. The BCI will be unprecedented in its small size, wireless and powered via induction so will not require batteries. Suitable for use at home, it will be capable of decoding speech in real-time to enable people with LIS to communicate with family and caregivers.

The project will further develop the Wyss Center’s fully implantable wireless ABILITY system to connect to customized electrocorticography (ECoG) electrode grids, developed by CorTec, that detect brain signals from the surface of the brain. The ambitious timeline aims for full implant development and verification in the first two years of the project, with the second two years focusing on clinical studies and algorithm improvements to restore communication in locked-in patients with amyotrophic lateral sclerosis (ALS) or brainstem stroke. ALS is a progressive neurodegenerative disease in which people gradually lose the ability to move and talk, eventually all means of communication are lost, leaving patients isolated. Brainstem stroke can render people unable to speak or move, without recovery.

"As a first step to enable the patients to interact with the system, we will set up the decoding for mouse clicks and cursor control from intended movements, which we have shown to be feasible in previous research," explains Prof. Dr. Gernot Müller-Putz, Head of the Institute of Neural Engineering and its associated Laboratory of Brain-Computer Interfaces at the Graz University of Technology.

"Our BCI system will go far beyond current technology," says Prof. Nick Ramsey from the UMC Utrecht Brain Center, the Netherlands, who coordinates the project. "We want to create a sustainable, high-resolution BCI by combining state-of-the-art hardware and software based on artificial intelligence (AI)."

"This new project builds on the promising preliminary data from our clinical study enabling communication with a completely locked-in participant, and our pre-clinical study currently underway with the wireless, implantable ABILITY device." said Dr. Jonas Zimmermann, Senior Neuroscientist at the Wyss Center. "In this project we will record from a larger area of the brain and explore new decoding algorithms that have the potential to tackle important clinical and social needs for people with ALS but also for those with other neurological conditions that impair movement and communication."

Dr. Tracy Laabs, Chief Development Officer at the Wyss Center, is excited: "After several years of prototype developments, this project will allow us to make the crucial final steps that will bring our system to the patient."

The BCI system will be trialed in two people with locked-in syndrome in the home environment. The brain surface-lining electrode grids will collect high resolution neural data that will be decoded using AI algorithms to translate the brain signals to computer speech in real-time.

The research project 'Intracranial Neurotelemetry to Restore Communication' (INTRECOM) is part of the EIC Pathfinder Challenge program in which the European Innovation Council supports visionary, entrepreneurial researchers who have bold ideas for radically new technologies. The Swiss participants receive support from the Swiss State Secretariat for Education, Research and Innovation (SERI).

About the Wyss Center for Bio and Neuroengineering

The Wyss Center is an independent, non-profit, research and development organization that advances our understanding of the brain to realize therapies and improve lives.

The Wyss Center staff, together with the Center's academic, clinical and industrial collaborators, pursue innovations and new approaches in neurobiology, neuroimaging and neurotechnology.

Wyss Center advances reveal unique insights into the mechanisms underlying the dynamics of the brain and the treatment of disease to accelerate the development of devices and therapies for unmet medical needs.

The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center accelerate its mission.

http://www.wysscenter.ch

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...